JP2017529396A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017529396A5 JP2017529396A5 JP2017534526A JP2017534526A JP2017529396A5 JP 2017529396 A5 JP2017529396 A5 JP 2017529396A5 JP 2017534526 A JP2017534526 A JP 2017534526A JP 2017534526 A JP2017534526 A JP 2017534526A JP 2017529396 A5 JP2017529396 A5 JP 2017529396A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- pif peptide
- composition
- cells
- transplantation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462051077P | 2014-09-16 | 2014-09-16 | |
| US62/051,077 | 2014-09-16 | ||
| US201562113298P | 2015-02-06 | 2015-02-06 | |
| US62/113,298 | 2015-02-06 | ||
| US201562211660P | 2015-08-28 | 2015-08-28 | |
| US62/211,660 | 2015-08-28 | ||
| PCT/US2015/050532 WO2016044493A1 (en) | 2014-09-16 | 2015-09-16 | Compositions and methods for treating acute radiation syndrome |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020201734A Division JP2021046432A (ja) | 2014-09-16 | 2020-12-04 | 急性放射線症候群を治療するための組成物及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017529396A JP2017529396A (ja) | 2017-10-05 |
| JP2017529396A5 true JP2017529396A5 (https=) | 2018-11-01 |
| JP6806685B2 JP6806685B2 (ja) | 2021-01-06 |
Family
ID=55533820
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017534526A Active JP6806685B2 (ja) | 2014-09-16 | 2015-09-16 | 急性放射線症候群を治療するための組成物及び方法 |
| JP2020201734A Pending JP2021046432A (ja) | 2014-09-16 | 2020-12-04 | 急性放射線症候群を治療するための組成物及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020201734A Pending JP2021046432A (ja) | 2014-09-16 | 2020-12-04 | 急性放射線症候群を治療するための組成物及び方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US20170319645A1 (https=) |
| EP (1) | EP3193903A4 (https=) |
| JP (2) | JP6806685B2 (https=) |
| CN (1) | CN106999534A (https=) |
| AU (3) | AU2015317771A1 (https=) |
| CA (1) | CA2961375A1 (https=) |
| IL (2) | IL295025A (https=) |
| WO (1) | WO2016044493A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017039751A1 (en) | 2015-08-28 | 2017-03-09 | Bioincept, Llc | Mutant peptides and methods of treating subjects using the same |
| AU2016317574A1 (en) | 2015-08-28 | 2018-03-29 | Bioincept, Llc | Compositions and methods for the treatment of neurodamage |
| AU2018225163A1 (en) * | 2017-02-22 | 2019-09-19 | Bioincept, Llc | Peptides and methods of treating dystrophy-related disorders using the same |
| AU2018304200A1 (en) * | 2017-07-17 | 2020-02-13 | Bioincept, Llc | Peptides and methods of transplantation and restorative organ function |
| WO2022047196A1 (en) * | 2020-08-28 | 2022-03-03 | Nisibis, Llc-S | Pten inhibitors for treatment and prevention of bone marrow loss |
| WO2023056075A1 (en) * | 2021-10-01 | 2023-04-06 | The Regents Of The University Of Colorado, A Body Corporate | Compositions and methods for reduced toxicity in transplantation using janus kinase (jak) inhibitors |
| EP4248985A1 (en) * | 2022-03-25 | 2023-09-27 | Consejo Superior de Investigaciones Científicas (CSIC) | Peptides for the treatment of retinitis pigmentosa |
| WO2025117717A1 (en) * | 2023-11-27 | 2025-06-05 | The Brigham And Women’S Hospital, Inc. | Skin based test for detection of radiation exposure |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4629722A (en) * | 1984-07-12 | 1986-12-16 | Ribi Immunochem Research, Inc. | Method of inhibiting the onset of acute radiation syndrome |
| US7723290B2 (en) * | 2004-10-22 | 2010-05-25 | Bioincept, Llc | Compositions and methods for modulating the immune system |
| CA2584690C (en) * | 2003-10-22 | 2015-10-06 | Bioincept, Llc | Pif peptides biologic activities, site of action, and the antibody to detect pif |
| US9737585B2 (en) * | 2011-03-02 | 2017-08-22 | Bioincept, Llc | Compositions and methods for treatment of intracellular damage and bacterial infection |
| JP6416627B2 (ja) * | 2012-01-09 | 2018-10-31 | セルピン ファーマ リミテッド ライアビリティ カンパニー | ペプチドおよびその使用法 |
| US20160263186A1 (en) * | 2013-10-22 | 2016-09-15 | Bioincept, Llc | Pif-transfected cells and methods of use |
-
2015
- 2015-09-16 IL IL295025A patent/IL295025A/en unknown
- 2015-09-16 EP EP15842062.0A patent/EP3193903A4/en not_active Withdrawn
- 2015-09-16 CA CA2961375A patent/CA2961375A1/en not_active Abandoned
- 2015-09-16 WO PCT/US2015/050532 patent/WO2016044493A1/en not_active Ceased
- 2015-09-16 CN CN201580061796.4A patent/CN106999534A/zh active Pending
- 2015-09-16 US US15/512,001 patent/US20170319645A1/en not_active Abandoned
- 2015-09-16 JP JP2017534526A patent/JP6806685B2/ja active Active
- 2015-09-16 AU AU2015317771A patent/AU2015317771A1/en not_active Abandoned
- 2015-09-16 IL IL251108A patent/IL251108B/en unknown
-
2019
- 2019-04-18 AU AU2019202741A patent/AU2019202741A1/en not_active Abandoned
-
2020
- 2020-12-04 JP JP2020201734A patent/JP2021046432A/ja active Pending
-
2021
- 2021-04-16 AU AU2021202310A patent/AU2021202310A1/en not_active Abandoned
- 2021-09-10 US US17/472,574 patent/US20220249595A1/en not_active Abandoned
-
2024
- 2024-05-31 US US18/731,133 patent/US12458681B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017529396A5 (https=) | ||
| Lee et al. | Heme oxygenase‐1, carbon monoxide, and bilirubin induce tolerance in recipients toward islet allografts by modulating T regulatory cells | |
| Kim et al. | Comparison of four pancreatic islet implantation sites | |
| US20070202083A1 (en) | Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis | |
| JP2022088551A (ja) | 増殖造血幹細胞／前駆細胞集団の利用 | |
| CN102083426A (zh) | 与非大麻素化学治疗剂(例如血清或者烷基化剂)相组合的大麻素 | |
| KR20150065881A (ko) | 암 표적화 치료 및 암 재발 예방을 위한 헤모글로빈 기반 산소운반체 함유 약학적 조성물 | |
| JP2016537380A5 (https=) | ||
| RU2014124171A (ru) | Лекарственное средство для терапевтического лечения и/или улучшения состояния при сепсисе | |
| TW201716059A (zh) | 新穎方法 | |
| JP2020531529A5 (https=) | ||
| CN114732807A (zh) | 米托蒽醌在制备预防或治疗急性移植物抗宿主病药物中的应用 | |
| KR102712578B1 (ko) | 혈관화 조직을 유전적으로 변형시키는 방법 | |
| AU2017376704A1 (en) | Composition, application thereof and treatment method | |
| WO2020069488A1 (en) | Compositions and methods for drug delivery | |
| Jung et al. | Efficacy of stem cell mobilization in patients with newly diagnosed multiple myeloma after a CTD (cyclophosphamide, thalidomide, and dexamethasone) regimen | |
| JP4846151B2 (ja) | 骨髄もしくは血液幹細胞の移植前の患者のコンディショニングのためのトレオスルファンの使用 | |
| Hawthorne et al. | Outcomes for islet transplantation in donation after circulatory death compared with donation after brain death in Australia | |
| Kuroiwa et al. | Effects of recombinant human endostatin on a human neuroblastoma xenograft | |
| TWI889188B (zh) | 母帕司汀（Muparfostat）用於製備治療胰臟癌之醫藥組成物的用途 | |
| JP2021130679A (ja) | 造血幹細胞移植患者の処置 | |
| Jeon et al. | Cultured human chromaffin cells grafted in spinal subarachnoid space relieves allodynia in a pain rat model | |
| Gruchet et al. | Pomalidomide 3rd line versus 4th line for in Early Relapsed Refractory Multiple Myeloma | |
| Dajani et al. | Treating diabetes with islet cell transplantation: lessons from the Edmonton experience | |
| Singh et al. | Transplanting fragments of diabetic pancreas into activated omentum gives rise to new insulin producing cells |